Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 750

1.

Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer's Disease Spectrum.

Therriault J, Wang S, Mathotaarachchi S, Pascoal TA, Parent M, Beaudry T, Shin M, Al B, Kang MS, Ng KP, Dansereau C, Park MTM, Fonov V, Carbonell F, Zimmer E, Chakravarty MM, Bellec P, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2019 Jun 22. doi: 10.1007/s12035-019-01671-0. [Epub ahead of print]

PMID:
31230260
2.

Aβ-induced vulnerability propagates via the brain's default mode network.

Pascoal TA, Mathotaarachchi S, Kang MS, Mohaddes S, Shin M, Park AY, Parent MJ, Benedet AL, Chamoun M, Therriault J, Hwang H, Cuello AC, Misic B, Soucy JP, Aston JAD, Gauthier S, Rosa-Neto P.

Nat Commun. 2019 Jun 4;10(1):2353. doi: 10.1038/s41467-019-10217-w.

3.

Aligning direct observation and assessment.

Gauthier S.

Med Educ. 2019 Jul;53(7):642-644. doi: 10.1111/medu.13903. Epub 2019 May 20. No abstract available.

PMID:
31106882
4.

Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.

Zhang S, Nguyen TD, Hurtado Rúa SM, Kaunzner UW, Pandya S, Kovanlikaya I, Spincemaille P, Wang Y, Gauthier SA.

AJNR Am J Neuroradiol. 2019 Jun;40(6):987-993. doi: 10.3174/ajnr.A6071. Epub 2019 May 16.

PMID:
31097429
5.

Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.

Gauthier S, Alam J, Fillit H, Iwatsubo T, Liu-Seifert H, Sabbagh M, Salloway S, Sampaio C, Sims JR, Sperling B, Sperling R, Welsh-Bohmer KA, Touchon J, Vellas B, Aisen P.

J Prev Alzheimers Dis. 2019;6(3):164-168. doi: 10.14283/jpad.2019.12.

PMID:
31062826
6.

Taxonomy, together with ontogeny and growing conditions, drives needleleaf species' sensitivity to climate in boreal North America.

Marchand W, Girardin MP, Hartmann H, Gauthier S, Bergeron Y.

Glob Chang Biol. 2019 Apr 23. doi: 10.1111/gcb.14665. [Epub ahead of print]

PMID:
31012507
7.

Users' perspectives on medical assistance in dying for persons with dementia.

Gauthier S, Gagnon L, Rochon A.

Int J Geriatr Psychiatry. 2019 Jul;34(7):905. doi: 10.1002/gps.5115. Epub 2019 Apr 29. No abstract available.

PMID:
30958580
8.

Disconnection Between Self-Reported and Objective Cognitive Impairment in Obstructive Sleep Apnea.

Gagnon K, Baril AA, Montplaisir J, Carrier J, De Beaumont L, D'Aragon C, Chami S, Pelleieux S, Poirier J, Gauthier S, Lafond C, Gagnon JF, Gosselin N.

J Clin Sleep Med. 2019 Mar 15;15(3):409-415. doi: 10.5664/jcsm.7664.

PMID:
30853044
9.

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.

Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR Jr, Farlow MR, Salloway S, Snider BJ, Berman SB, Roberson ED, Brosch J, Jimenez-Velazques I, van Dyck CH, Galasko D, Yuan SH, Jayadev S, Honig LS, Gauthier S, Hsiung GR, Masellis M, Brooks WS, Fulham M, Clarnette R, Masters CL, Wallon D, Hannequin D, Dubois B, Pariente J, Sanchez-Valle R, Mummery C, Ringman JM, Bottlaender M, Klein G, Milosavljevic-Ristic S, McDade E, Xiong C, Morris JC, Bateman RJ, Benzinger TLS.

Alzheimers Dement (Amst). 2019 Feb 22;11:180-190. doi: 10.1016/j.dadm.2018.12.008. eCollection 2019 Dec.

10.

Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer's Disease with De Novo PSEN1 Mutation.

Liu J, Wang Q, Jing D, Gao R, Zhang J, Cui C, Qiao H, Liang Z, Wang C, Rosa-Neto P, Wu L, Jia J, Gauthier S.

J Alzheimers Dis. 2019;68(2):551-558. doi: 10.3233/JAD-181108.

PMID:
30814350
11.

PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.

Kang Y, Gauthier SA.

Mult Scler. 2019 Jul;25(8):1090-1091. doi: 10.1177/1352458519828299. Epub 2019 Feb 27. No abstract available.

PMID:
30810087
12.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review.

PMID:
30787160
13.

Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders.

Chhetri JK, Chan P, Vellas B, Touchon J, Gauthier S.

J Prev Alzheimers Dis. 2019;6(2):144-147. doi: 10.14283/jpad.2019.2.

PMID:
30756122
14.

Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS.

Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019.

PMID:
30753379
15.

Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Guillo Benarous F, Ulysse A, Oo T, Vedvyas A, Rao JA, Marsh K, Kluger A, Sangha J, Hassan M, Alshalabi M, Arain F, Shaikh N, Buj M, Kenowsky S, Masurkar AV, Rabin L, Noroozian M, Sánchez-Saudinós MAB, Blesa R, Auer S, Zhang Y, de Leon M, Sadowski M, Wisniewski T, Gauthier S, Shao Y.

J Alzheimers Dis. 2019;67(2):685-705. doi: 10.3233/JAD-180341.

PMID:
30689585
16.

Openness, inclusion, and respect in dementia research.

Thorogood A, Mäki-Petäjä-Leinonen A, Dalpé G, Gastmans C, Gauthier S.

Lancet Neurol. 2019 Feb;18(2):135-136. doi: 10.1016/S1474-4422(18)30445-9. No abstract available.

PMID:
30663603
17.

IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.

Gauthier SD, Moutuou MM, Daudelin F, Leboeuf D, Guimond M.

Biol Blood Marrow Transplant. 2019 Apr;25(4):648-655. doi: 10.1016/j.bbmt.2018.12.066. Epub 2018 Dec 19.

PMID:
30576835
18.

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA.

Brain. 2019 Jan 1;142(1):133-145. doi: 10.1093/brain/awy296.

PMID:
30561514
19.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2018 Nov 9. doi: 10.1007/s12035-018-1405-1. [Epub ahead of print]

PMID:
30414086
20.

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.

Zhang H, Ng KP, Therriault J, Kang MS, Pascoal TA, Rosa-Neto P, Gauthier S; Alzheimer’s Disease Neuroimaging Initiative.

Transl Neurodegener. 2018 Sep 10;7:23. doi: 10.1186/s40035-018-0127-7. eCollection 2018.

21.

Consent recommendations for research and international data sharing involving persons with dementia.

Thorogood A, Mäki-Petäjä-Leinonen A, Brodaty H, Dalpé G, Gastmans C, Gauthier S, Gove D, Harding R, Knoppers BM, Rossor M, Bobrow M; Global Alliance for Genomics and Health, Ageing and Dementia Task Team.

Alzheimers Dement. 2018 Oct;14(10):1334-1343. doi: 10.1016/j.jalz.2018.05.011. Epub 2018 Jul 2.

22.

The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia.

Ng KP, Chiew HJ, Lim L, Rosa-Neto P, Kandiah N, Gauthier S.

Expert Rev Neurother. 2018 Nov;18(11):859-869. doi: 10.1080/14737175.2018.1532792. Epub 2018 Oct 10.

PMID:
30286681
23.

Resident and attending perceptions of direct observation in internal medicine: a qualitative study.

Gauthier S, Melvin L, Mylopoulos M, Abdullah N.

Med Educ. 2018 Dec;52(12):1249-1258. doi: 10.1111/medu.13680. Epub 2018 Oct 1.

PMID:
30276856
24.

Interpersonal Synchronization, Motor Coordination, and Control Are Impaired During a Dynamic Imitation Task in Children With Autism Spectrum Disorder.

Xavier J, Gauthier S, Cohen D, Zahoui M, Chetouani M, Villa F, Berthoz A, Anzalone S.

Front Psychol. 2018 Sep 3;9:1467. doi: 10.3389/fpsyg.2018.01467. eCollection 2018.

25.

Surface manipulation of a curved polycyclic aromatic hydrocarbon-based nano-vehicle molecule equipped with triptycene wheels.

Soe WH, Durand C, Guillermet O, Gauthier S, de Rouville HJ, Srivastava S, Kammerer C, Rapenne G, Joachim C.

Nanotechnology. 2018 Dec 7;29(49):495401. doi: 10.1088/1361-6528/aae0d9. Epub 2018 Sep 12.

PMID:
30207539
26.

Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea.

Gagnon K, Baril AA, Montplaisir J, Carrier J, Chami S, Gauthier S, Lafond C, Gagnon JF, Gosselin N.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801137. doi: 10.1183/13993003.01137-2018. Print 2018 Nov.

PMID:
30190270
27.

Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

Kaur G, Gauthier SA, Perez-Gonzalez R, Pawlik M, Singh AB, Cosby B, Mohan PS, Smiley JF, Levy E.

Neurobiol Dis. 2018 Dec;120:165-173. doi: 10.1016/j.nbd.2018.08.025. Epub 2018 Sep 1.

PMID:
30176349
28.

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.

Zhang H, Therriault J, Kang MS, Ng KP, Pascoal TA, Rosa-Neto P, Gauthier S; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2018 Aug 16;10(1):80. doi: 10.1186/s13195-018-0407-6.

29.

Does time since fire drive live aboveground biomass and stand structure in low fire activity boreal forests? Impacts on their management.

Portier J, Gauthier S, Cyr G, Bergeron Y.

J Environ Manage. 2018 Nov 1;225:346-355. doi: 10.1016/j.jenvman.2018.07.100. Epub 2018 Aug 6.

30.

Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.

Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.

PLoS One. 2018 Aug 9;13(8):e0201289. doi: 10.1371/journal.pone.0201289. eCollection 2018.

31.

Optimal use of cholinergic drugs in Alzheimer's disease.

Gauthier S, Herrmann N, Rosa-Neto P.

Brain. 2018 Sep 1;141(9):e68. doi: 10.1093/brain/awy204. No abstract available.

PMID:
30084978
32.

In vivo quantification of neurofibrillary tangles with [18F]MK-6240.

Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, Bennacef I, Therriault J, Ng KP, Hopewell R, Bouhachi R, Hsiao HH, Benedet AL, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P.

Alzheimers Res Ther. 2018 Jul 31;10(1):74. doi: 10.1186/s13195-018-0402-y.

33.

Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.

Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA.

Neuroimage Clin. 2018 May 8;19:417-424. doi: 10.1016/j.nicl.2018.05.003. eCollection 2018.

34.

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial.

Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Shi L, Gong M, Xu H, Li F, He J, Song H, Yang S, Zhou A, Wang F, Zuo X, Chu C, Liang J, Jia L, Gauthier S.

Alzheimers Dement (N Y). 2018 Mar 22;4:108-117. doi: 10.1016/j.trci.2018.02.004. eCollection 2018.

35.

Expert Consensus on Clinical Diagnostic Criteria for Fatal Familial Insomnia.

Wu LY, Zhan SQ, Huang ZY, Zhang B, Wang T, Liu CF, Lu H, Dong XP, Wu ZY, Zhang JW, Zhang JH, Zhao ZX, Han F, Huang Y, Lu J, Gauthier S, Jia JP, Wang YP.

Chin Med J (Engl). 2018 Jul 5;131(13):1613-1617. doi: 10.4103/0366-6999.235115. No abstract available.

36.

Behavioral Own-Body-Transformations in Children and Adolescents With Typical Development, Autism Spectrum Disorder, and Developmental Coordination Disorder.

Gauthier S, Anzalone SM, Cohen D, Zaoui M, Chetouani M, Villa F, Berthoz A, Xavier J.

Front Psychol. 2018 May 25;9:676. doi: 10.3389/fpsyg.2018.00676. eCollection 2018.

37.

Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

Gauthier S, Zhang H, Ng KP, Pascoal TA, Rosa-Neto P.

Transl Neurodegener. 2018 May 31;7:12. doi: 10.1186/s40035-018-0117-9. eCollection 2018. Review.

38.

New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS.

Alzheimers Dement. 2018 Jun;14(6):703-706. doi: 10.1016/j.jalz.2018.05.002. Epub 2018 May 26. No abstract available.

PMID:
29842864
39.

Influence of Cu adatoms on the molecular assembly of 4,4'-bipyridine on Cu(111).

Dubois MA, Guillermet O, Gauthier S, Zhan G, Makoudi Y, Palmino F, Bouju X, Rochefort A.

Phys Chem Chem Phys. 2018 Jun 6;20(22):15350-15357. doi: 10.1039/c8cp01184b.

PMID:
29796573
40.

Individual variation, population-specific behaviours and stochastic processes shape marine migration phenologies.

Freshwater C, Trudel M, Beacham TD, Gauthier S, Johnson SC, Neville CE, Juanes F.

J Anim Ecol. 2019 Jan;88(1):67-78. doi: 10.1111/1365-2656.12852. Epub 2018 Jun 12.

PMID:
29790171
41.

Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.

Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J, Sullivan JM, Pryor KO, Hesterman J, Kothari PJ, Vallabhajosula S.

J Neuroimaging. 2018 Sep;28(5):496-505. doi: 10.1111/jon.12519. Epub 2018 May 4.

42.

Acute prediction of outcome and cognitive-communication impairments following traumatic brain injury: The influence of age, education and site of lesion.

Gauthier S, LeBlanc J, Seresova A, Laberge-Poirier A, A Correa J, Alturki AY, Marcoux J, Maleki M, Feyz M, de Guise E.

J Commun Disord. 2018 May - Jun;73:77-90. doi: 10.1016/j.jcomdis.2018.04.003. Epub 2018 Apr 14.

PMID:
29709658
43.

Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.

Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.

J Neurol. 2018 May;265(5):1226-1229. doi: 10.1007/s00415-018-8845-4. Epub 2018 Apr 17.

PMID:
29666985
44.

Current and projected cumulative impacts of fire, drought, and insects on timber volumes across Canada.

Boucher D, Boulanger Y, Aubin I, Bernier PY, Beaudoin A, Guindon L, Gauthier S.

Ecol Appl. 2018 Jul;28(5):1245-1259. doi: 10.1002/eap.1724. Epub 2018 Jun 5.

PMID:
29645330
45.

Fast and Robust Unsupervised Identification of MS Lesion Change Using the Statistical Detection of Changes Algorithm.

Nguyen TD, Zhang S, Gupta A, Zhao Y, Gauthier SA, Wang Y.

AJNR Am J Neuroradiol. 2018 May;39(5):830-833. doi: 10.3174/ajnr.A5594. Epub 2018 Mar 8.

46.

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Deh K, Ponath GD, Molvi Z, Parel GT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A, Gauthier SA, Pitt D, Wang Y.

J Magn Reson Imaging. 2018 Nov;48(5):1281-1287. doi: 10.1002/jmri.25997. Epub 2018 Mar 8.

PMID:
29517817
47.

Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.

Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P.

J Alzheimers Dis. 2018;64(s1):S23-S31. doi: 10.3233/JAD-179924. Review.

48.

Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.

Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J; Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group.

JAMA Neurol. 2018 May 1;75(5):608-619. doi: 10.1001/jamaneurol.2017.5135.

49.

Corrigendum to "Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation"[NeuroImage 129 (2016) 1-14].

Schoemaker D, Buss C, Head K, Sandman CA, Davis EP, Chakravarty MM, Gauthier S, Pruessner JC.

Neuroimage. 2018 Jun;173:1-2. doi: 10.1016/j.neuroimage.2018.02.009. Epub 2018 Feb 21. No abstract available.

PMID:
29477029
50.

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurol Genet. 2018 Jan 30;4(1):e216. doi: 10.1212/NXG.0000000000000216. eCollection 2018 Feb.

Supplemental Content

Loading ...
Support Center